Sermorelin vs Tesamorelin
Both prompt the pituitary gland to release growth hormone. One is an approved drug with a single narrow use; the other was approved, discontinued and is now compounded.
Side-by-side facts · No recommendation · Reviewed
SermorelinTesamorelinSame for both
| Sermorelin | Tesamorelin | |
|---|---|---|
| What it is | Fragment of growth-hormone-releasing hormone | Growth-hormone-releasing hormone analog |
| Status today | No approved product on the market; compounded on prescription | FDA-approved (Egrifta) for one use |
| Approved use | Was approved in 1997 for growth hormone deficiency in children (discontinued 2008) | Reducing excess abdominal fat in people with HIV who have lipodystrophy |
| Compounding | Compounded by pharmacies | Not eligible: FDA treats it as a biological product |
| Evidence | Pediatric data from its approved years; limited data for adult uses promoted today | Two placebo-controlled trials in 816 adults with HIV |
Key differences
Tesamorelin is an approved drug, but only for abdominal fat in people with HIV-associated lipodystrophy. It is not approved for general weight loss.
Sermorelin was approved as Geref in 1997 and discontinued by its maker in 2008. FDA later confirmed the withdrawal was not for safety or effectiveness reasons. Today it is obtained through compounding pharmacies, so quality depends on the pharmacy.
Side effects
For tesamorelin, joint pain, injection-site reactions, stomach pain, swelling and muscle pain were the most common, and blood sugar control worsened more often than with placebo.
Questions
Is sermorelin the same as tesamorelin?
No. Both act on the same pathway, but they are different molecules with different regulatory histories.
Is sermorelin FDA approved?
Not today. It was approved in 1997 and discontinued in 2008. It is now compounded on prescription.
Which compound, if any, suits a person is a decision for them and a licensed prescriber. This page compares published facts and does not recommend either.
Sources: Portrait: is sermorelin FDA approved; News-Medical: Egrifta FDA approval; Portrait: sermorelin and tesamorelin FDA records.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.